Welcome to the ValueWiki Symbollon Pharmaceuticals, Inc. Class A (SYMBA) article! Register for free or click the "edit" link to contribute!

Symbollon Pharmaceuticals, Inc. Class A (SYMBA)

From ValueWiki

Jump to: navigation, search

Launch Chat Window

OTC \ Healthcare \ Drug Delivery

Business Description from Pinksheets.com: Speciality pharmaceutical company focused on development of iodine based products for the women's health and antimicrobial markets.^[1]

You can add information to this page! Just click any blue [ edit ] link to contribute.

1 Company Analysis
2 News Feed
3 Leadership
4 Risks
5 Research Links
6 Notes

Today

Max

[edit]

Company Analysis

Symbollon Pharmaceuticals, Inc. Class A Snapshot^[1]

Outstading Shares: 6,114,761 as of 2004-12-31
Transfer Agent: American Stock Transfer & Trust Company, New York, NY 10038

Symbollon Pharmaceuticals, Inc. Class A Contact Information

Address: 37 Loring Drive Framingham, MA 01702 USA
Website: http://www.symbollon.com
Phone: 508-620-7676
Fax: 508-620-7111

[edit]

News Feed

11/29/08 9:11 am	SYMBOLLON CORP Financials (EDGAR Online Financials)
11/19/08 11:11 am	Symbollon Initiates Sales of IoGen Through Web Site BuyIoGen.com (Marketwire)
11/14/08 3:11 pm	Symbollon Pharmaceuticals Announces Third Quarter 2008 Results (Marketwire)
11/14/08 11:11 am	SYMBOLLON CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)
09/18/08 10:09 am	Symbollon to Exhibit at the Natural Products Expo East (Marketwire)
08/14/08 11:08 am	Symbollon Pharmaceuticals Announces Second Quarter 2008 Results (Marketwire)
08/14/08 10:08 am	SYMBOLLON CORP Files SEC form 10-Q, Quarterly Report (EDGAR Online)
05/19/08 11:05 am	SYMBOLLON CORP Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online)
05/16/08 10:05 am	Symbollon Pharmaceuticals Announces First Quarter 2008 Results (Marketwire)
04/10/08 7:04 am	Symbollon Pharmaceuticals Announces Results of IoGen Phase III Clinical Trial (Marketwire)